公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2021 | APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy | Lau G.; Yu M.-L.; Wong G.; Thompson A.; Ghazinian H.; Hou J.-L.; Piratvisuth T.; Jia J.-D.; Mizokami M.; Cheng G.; Chen G.-F.; Liu Z.-W.; Baatarkhuu O.; ANN-LII CHENG ; Ng W.L.; Lau P.; Mok T.; Chang J.-M.; Hamid S.; Dokmeci A.K.; Gani R.A.; Payawal D.A.; Chow P.; Park J.-W.; Strasser S.I.; Mohamed R.; Win K.M.; Tawesak T.; Sarin S.K.; Omata M. | Hepatology International | 52 | 41 | |
2012 | Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update | Liaw Y.-F.; JIA-HORNG KAO ; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU ; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M. | Hepatology International | 835 | 785 | |
2016 | Chronic Hepatitis B virus infection | Yuen M.-F.; Ahn S.H.; Chen D.-S.; PEI-JER CHEN ; Dusheiko G.M.; Hou J.-L.; Maddrey W.C.; Mizokami M.; Seto W.-K.; Zoulim F.; Lai C.-L. | Journal of Clinical Gastroenterology | 36 | 41 | |
2010 | Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy | Lui Y.Y.-N.; Tsoi K.K.-F.; Wong V.W.-S.; JIA-HORNG KAO ; Hou J.-L.; Teo E.-K.; Mohamed R.; Piratvisuth T.; Han K.-H.; Mihm U.; Wong G.L.-H.; Chan H.L.-Y. | Antiviral Therapy | 35 | 37 | |
2012 | Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update (Hepatology International (2012) 6 (531-561) DOI: 10.1007/s12072-012-9365-4) | Liaw Y.-F.; JIA-HORNG KAO ; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU ; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M. | Hepatology International | 16 | 18 |